[go: up one dir, main page]

ES8404188A1 - Procedimiento para proteger anfitriones susceptibles de infeccion de hepatitis. - Google Patents

Procedimiento para proteger anfitriones susceptibles de infeccion de hepatitis.

Info

Publication number
ES8404188A1
ES8404188A1 ES515472A ES515472A ES8404188A1 ES 8404188 A1 ES8404188 A1 ES 8404188A1 ES 515472 A ES515472 A ES 515472A ES 515472 A ES515472 A ES 515472A ES 8404188 A1 ES8404188 A1 ES 8404188A1
Authority
ES
Spain
Prior art keywords
serum albumin
adjuvant
polymerized
vaccine
polymerized serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES515472A
Other languages
English (en)
Other versions
ES515472A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Publication of ES8404188A1 publication Critical patent/ES8404188A1/es
Publication of ES515472A0 publication Critical patent/ES515472A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE UNA VACUNA DE UTILIDAD PARA LA VACUNACION DE UN ANFITRION MAMIFERO CONTRA LA HEPATITIS.CONSISTE EN COMBINAR ALBUMINA DE SUERO POLIMERIZADA CON UN ADYUVANTE INMUNOGENICO, TENIENDO DICHA ALBUMINA DE SUERO POLIMERIZADA DE 6 A 12 UNIDADES APROXIMADAMENTE, Y ESTANDO SUSTANCIALMENTE LIBRE DE OTRAS PROTEINAS Y MATERIALES GENETICOS DERIVADOS DE VIRUS HEPATOTROPICOS. LA ALBUMINA DE SUERO POLIMERIZADA SE FRACCIONA PARA ASEGURAR EL TAMAÑO ADECUADO ANTES DE LA COMBINACION CON EL ADYUVANTE.
ES515472A 1981-09-04 1982-09-03 Procedimiento para proteger anfitriones susceptibles de infeccion de hepatitis. Granted ES515472A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29945281A 1981-09-04 1981-09-04

Publications (2)

Publication Number Publication Date
ES8404188A1 true ES8404188A1 (es) 1984-04-16
ES515472A0 ES515472A0 (es) 1984-04-16

Family

ID=23154848

Family Applications (1)

Application Number Title Priority Date Filing Date
ES515472A Granted ES515472A0 (es) 1981-09-04 1982-09-03 Procedimiento para proteger anfitriones susceptibles de infeccion de hepatitis.

Country Status (6)

Country Link
EP (1) EP0074248B1 (es)
JP (1) JPS5883631A (es)
AT (1) ATE18007T1 (es)
AU (1) AU554859B2 (es)
DE (1) DE3269188D1 (es)
ES (1) ES515472A0 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1248565B (it) * 1991-06-27 1995-01-19 Erba Carlo Spa Anticorpi policlonali anti-irudina e loro utilizzo per la identificazione, l`immunopurificazione e la determinazione quantitativa dell`uridina.
US6719975B1 (en) 1991-06-27 2004-04-13 Farmitalia Carlo Erba S.R.L. Anti-hirudin polyclonal antibodies and their use for the identification, immunopurification and quantitative determination of hirudin
US6682746B2 (en) 1995-09-21 2004-01-27 Kristina J. Hennessy Adjuvanted vaccine which is substantially free of non-host albumin
CA2184132C (en) 1995-09-21 2011-03-15 Kristina J. Hennessy An adjuvanted vaccine which is substantially free of non-host albumin
ES2330904B1 (es) 2005-09-21 2010-09-23 Fundacio Centre De Recerca En Sanitat Animal Polinucleotidos de haemophilus parasuis y su uso.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4046871A (en) * 1975-04-08 1977-09-06 Ortho Diagnostics Inc. Compositions and serological methods including bovine serum albumin polymers

Also Published As

Publication number Publication date
JPS5883631A (ja) 1983-05-19
EP0074248A2 (en) 1983-03-16
ES515472A0 (es) 1984-04-16
ATE18007T1 (de) 1986-03-15
DE3269188D1 (en) 1986-03-27
AU554859B2 (en) 1986-09-04
EP0074248A3 (en) 1983-09-28
EP0074248B1 (en) 1986-02-19
AU8778582A (en) 1983-03-10

Similar Documents

Publication Publication Date Title
ES2070997T3 (es) Virus de herpes recombinante de pavos y vacunas vector vivas derivadas de los mismos.
IT1164858B (it) Procedimento per la preparazione di vaccini a base di virus con proteine superficiali ricombinanti e prodotto ottenuto
CY1110359T1 (el) Εμβολια με βαση σιρκοϊους χοιρων
ATE144143T1 (de) Künstlicher impfstoff gegen aids-virus
EA199800272A1 (ru) Фактор, стимулирующий дендритные клетки
ES2100240T3 (es) Bacteriofagos modificados mediante ingenieria genetica y vacunas que los contienen.
EA200000528A1 (ru) Способ получения вакцин для предупреждения патогенных эффектов, связанных с ретровирусной инфекцией
NO167359C (no) Fremgangsmaate for fremstilling av en vaksine mot infeksjon av hepatitis b virus.
PE97298A1 (es) Composicion para vacunas
ES2041796T3 (es) Un procedimiento para preparar una vacuna.
KR860004146A (ko) 경구용 백신의 제조방법
MX9304803A (es) Vacuna de virus de hepatitis a.
DK0480949T3 (da) Fremstilling af virus og oprensning af virale kappeproteiner til vaccineanvendelse
ES8404188A1 (es) Procedimiento para proteger anfitriones susceptibles de infeccion de hepatitis.
SE9903031D0 (sv) Peptide mixture and vaccine against a chronic viral infection
SE7602871L (sv) Vaccin for aktiv immunisering
EP0327180A3 (en) Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1
DE69922212D1 (de) Impfstoff enthaltend zytokin-induzierte heat shock proteine (hsp)
ATE86119T1 (de) Lebendvaccine fuer ansteckungskrankheiten von kueken.
FI923020A (fi) Inte a inte b-sekvenser.
DZ1550A1 (fr) Vaccin depourvu de cellules contre le virus de la maladie marek.
FR2620030B1 (fr) Vecteur d'expression des proteines du virus hiv-2, un agent causal du sida, culture cellulaire infectee ou transformee par ce vecteur, proteines obtenues, vaccin et anticorps obtenus
RO76563A2 (ro) Procedeu de stabilizare a unui vaccin antiherpetic
DK257887A (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
SE9202934D0 (sv) Vacciner mot melanom